Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.32B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$2.19B |
| 3 |
Apple
AAPL
|
+$2.17B |
| 4 |
NVIDIA
NVDA
|
+$2.12B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.74B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares China Large-Cap ETF
FXI
|
+$563M |
| 2 |
Jefferies Financial Group
JEF
|
+$510M |
| 3 |
SPDR Gold Trust
GLD
|
+$313M |
| 4 |
S&P Global
SPGI
|
+$286M |
| 5 |
CrowdStrike
CRWD
|
+$196M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.69% |
| 2 | Consumer Discretionary | 7.38% |
| 3 | Financials | 7.04% |
| 4 | Healthcare | 5.93% |
| 5 | Communication Services | 4.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BXMX
4801
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
| $34.8K | ﹤0.01% |
2,650
-536
| -17% | -$7.37K |
|
4802
Pampa Energía
PAM
$4.54B
| $34.7K | ﹤0.01% |
450
-58,302
| -99% | -$4.84M |
|
4803
Tilray
TLRY
$505M
| $34.7K | ﹤0.01% |
5,284
+598
| +13% | +$5.53K |
|
|
INZY
4804
DELISTED
Inozyme Pharma
INZY
| $34.7K | ﹤0.01% |
38,138
-2,265
| -6% | -$3.14K |
|
4805
Jasper Therapeutics
JSPR
$20.4M
| $34.6K | ﹤0.01% |
8,057
-1,003
| -11% | -$6.67K |
|
|
RDIB
4806
Reading International Class B
RDIB
| $34.6K | ﹤0.01% |
4,929
-56
| -1% | -$401 |
|
4807
dLocal
DLO
$4.42B
| $34.5K | ﹤0.01% |
4,132
-1,325
| -24% | -$14.9K |
|
4808
Pyxis Oncology
PYXS
$181M
| $34.3K | ﹤0.01% |
35,040
-7,048
| -17% | -$9.4K |
|
4809
Ituran Location and Control
ITRN
$1.09B
| $34.2K | ﹤0.01% |
947
+75
| +9% | +$2.7K |
|
4810
CION Investment
CION
$304M
| $33.9K | ﹤0.01% |
3,280
+129
| +4% | +$1.5K |
|
4811
Icahn Enterprises
IEP
$5.26B
| $33.9K | ﹤0.01% |
3,747
-8,960
| -71% | -$86.3K |
|
4812
Hagerty
HGTY
$1.24B
| $33.6K | ﹤0.01% |
3,712
+2,346
| +172% | +$22.7K |
|
4813
Acumen Pharmaceuticals
ABOS
$157M
| $32.8K | ﹤0.01% |
29,836
-50,509
| -63% | -$72.1K |
|
4814
NYLI FTSE International Equity Currency Neutral ETF
HFXI
$1.98B
| $32.8K | ﹤0.01% |
1,191
| – | – |
|
4815
Alto Neuroscience
ANRO
$1.07B
| $32.7K | ﹤0.01% |
15,144
-1,705
| -10% | -$6.1K |
|
4816
First Trust Exchange-Traded Fund VI Multi-Asset Diversified Income Index Fund
MDIV
$431M
| $32.7K | ﹤0.01% |
2,000
| – | – |
|
4817
Amprius Technologies
AMPX
$1.28B
| $32.6K | ﹤0.01% |
12,157
-3,351
| -22% | -$9.88K |
|
4818
Quest Resource Holding
QRHC
$28.4M
| $32.6K | ﹤0.01% |
12,531
-7,785
| -38% | -$36.9K |
|
4819
Meridian
MRBK
$244M
| $32.5K | ﹤0.01% |
2,258
-6,573
| -74% | -$100K |
|
|
BIOA
4820
BioAge Labs
BIOA
$945M
| $32.1K | ﹤0.01% |
8,537
-1,018
| -11% | -$4.71K |
|
4821
VirTra
VTSI
$36.7M
| $32K | ﹤0.01% |
7,858
-873
| -10% | -$5.22K |
|
4822
Invesco Food & Beverage ETF
PBJ
$112M
| $31.3K | ﹤0.01% |
680
| – | – |
|
|
PSIX
4823
Power Solutions International
PSIX
$640M
| $30.8K | ﹤0.01% |
1,217
-5,433
| -82% | -$187K |
|
4824
Purple Innovation
PRPL
$35.3M
| $30.7K | ﹤0.01% |
1,619
-219
| -12% | -$5.05K |
|
|
MRDN
4825
Meridian Holdings Inc
MRDN
$177M
| $30.3K | ﹤0.01% |
1,282
-88
| -6% | -$2.14K |
|
Similar funds
Citigroup's Q1 2025 Portfolio in Review
As of Q1 2025, Citigroup held 6,124 positions worth $196B, up 16% from $169B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Citigroup deployed $38.1B of net new capital in Q1 2025, opening 294 new positions and adding to 2,193 existing holdings. Its largest new stake was Boeing Co 6.00% Series A Preferred Stock: 2,013,956 shares worth $120M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares China Large-Cap ETF, an estimated $563M trimmed.
- Citigroup's largest Q1 2025 buy was Boeing Co 6.00% Series A Preferred Stock: 2,013,956 shares worth $120M.
- Citigroup added most to Microsoft in Q1 2025, an estimated $2.32B increase.
- Citigroup's biggest Q1 2025 reduction was iShares China Large-Cap ETF, cutting an estimated $563M.
- Citigroup fully exited Retail Opportunity Investments Corp. in Q1 2025, selling an estimated $46.9M.
- Citigroup's ten largest holdings make up 24% of its $196B portfolio in Q1 2025.
- Citigroup opened 294 new positions and closed 585 in Q1 2025.
- Citigroup's portfolio value rose 16% quarter-over-quarter to $196B.
Based on Citigroup's 13F filing for Q1 2025, filed 12 May 2025.